Showing 1 - 7 results of 7 for search 'Erik Skaaheim Haug', query time: 0.04s Refine Results
  1. 1
    Tumor cell invasion in blood vessels assessed by immunohistochemistry is related to decreased survival in patients with bladder cancer treated with radical cystectomy

    Tumor cell invasion in blood vessels assessed by immunohistochemistry is related to decreased survival in patients with bladder cancer treated with radical cystectomy by Birgitte Carlsen, Tor Audun Klingen, Bettina Kulle Andreassen, Erik Skaaheim Haug

    Published 2021-11-01
    Get full text
    Article
  2. 2
    Patient and tumour characteristics associated with inclusion in Cancer patient pathways in Norway in 2015–2016

    Patient and tumour characteristics associated with inclusion in Cancer patient pathways in Norway in 2015–2016 by Yngvar Nilssen, Odd Terje Brustugun, Morten Tandberg Eriksen, Erik Skaaheim Haug, Bjørn Naume, Bjørn Møller

    Published 2020-05-01
    Get full text
    Article
  3. 3
    Fear of Recurrence in Prostate Cancer Patients: A Cross-sectional Study After Radical Prostatectomy or Active Surveillance

    Fear of Recurrence in Prostate Cancer Patients: A Cross-sectional Study After Radical Prostatectomy or Active Surveillance by Rasmus Nilsson, Thomas F. Næss-Andresen, Tor Åge Myklebust, Tomm Bernklev, Hege Kersten, Erik Skaaheim Haug

    Published 2021-03-01
    Get full text
    Article
  4. 4
    No significant difference in intermediate key outcomes in men with low- and intermediate-risk prostate cancer managed by active surveillance

    No significant difference in intermediate key outcomes in men with low- and intermediate-risk prostate cancer managed by active surveillance by Karolina Cyll, Sven Löffeler, Birgitte Carlsen, Karin Skogstad, May Lisbeth Plathan, Martin Landquist, Erik Skaaheim Haug

    Published 2022-04-01
    Get full text
    Article
  5. 5
    Compliance with recommended cancer patient pathway timeframes and choice of treatment differed by cancer type and place of residence among cancer patients in Norway in 2015–2016

    Compliance with recommended cancer patient pathway timeframes and choice of treatment differed by cancer type and place of residence among cancer patients in Norway in 2015–2016 by Yngvar Nilssen, Odd Terje Brustugun, Morten Tandberg Eriksen, Marianne G. Guren, Erik Skaaheim Haug, Bjørn Naume, Ellen Schlichting, Bjørn Møller

    Published 2022-02-01
    Get full text
    Article
  6. 6
    Impact of prebiopsy MRI on prostate cancer staging: Results from the Norwegian Prostate Cancer Registry

    Impact of prebiopsy MRI on prostate cancer staging: Results from the Norwegian Prostate Cancer Registry by Erik Skaaheim Haug, Tor Åge Myklebust, Patrick Juliebø‐Jones, Lars Anders Rokne Reisæter, Kirsti Aas, Arne Stenrud Berg, Christoph Müller, Bjørn Hofmann, Øystein Størkersen, Kim L. Nilsen, Tom Børge Johannesen, Christian Beisland

    Published 2023-05-01
    Get full text
    Article
  7. 7
    PTEN and DNA Ploidy Status by Machine Learning in Prostate Cancer

    PTEN and DNA Ploidy Status by Machine Learning in Prostate Cancer by Karolina Cyll, Andreas Kleppe, Joakim Kalsnes, Ljiljana Vlatkovic, Manohar Pradhan, Wanja Kildal, Kari Anne R. Tobin, Trine M. Reine, Håkon Wæhre, Bjørn Brennhovd, Hanne A. Askautrud, Erik Skaaheim Haug, Tarjei S. Hveem, Håvard E. Danielsen

    Published 2021-08-01
    Get full text
    Article

Search Tools: